Novartis | NOVN - Interest Income



Novartis reported 6M in Interest Income for its fiscal quarter ending in March of 2024.


Interest Income Change Date
AbbVie USD 73M 19M Mar/2025
Almirall 2M 1.44M Mar/2025
AstraZeneca 68M 16M Jun/2025
Autolus Therapeutics Ltd 6.14M 1.31M Mar/2025
Bayer 92M 22M Mar/2025
Biogen USD 32.3M 8.4M Jun/2025
Eli Lilly USD 40M 8.3M Jun/2025
Fresenius Medical Care EUR 21.85M 6.87M Jun/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
Gilead Sciences 73M 21M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
GRIFOLS 9.56M 4.5M Jun/2025
Hikma Pharmaceutical 4M 0 Dec/2024
J&J 332M 51M Mar/2025
Merck 17M 11M Jun/2025
Merck USD 109M 37M Mar/2025
Pfizer USD 156M 13M Jun/2025
Philips 23M 10M Jun/2025
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Roche Holding 2M 12M Dec/2020
Sanofi 76M 10M Jun/2025